Approval · Notice of Compliance 15703 · 2014
NEXT CHOICE: Notice of Compliance 15703
Issued June 5, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15703
- Date
- June 5, 2014
- Company
- Actavis Pharma CompanyToronto, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Emergency contraception
- Canadian reference product
- PLAN B
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NEXT CHOICE | 02364905 | Cancelled Post Market |
Medicinal ingredients
- LEVONORGESTREL 0.75 MG per TAB